Total Beta Human Chorionic Gonadotropin eCLIA
- UID
- IMP/IVD/2022/000117_a059caeedc4b3103e6b385463559ec6b_f9ba431761d1e1885a5952cede6c024d
- Device class
- Class C
- Brand name
- eCLIA
- Approving authority
- CDSCO
- Product information
- Immunoassay for in vitro quantitative determination of human chorionic gonadotropin in human serum and plasma. This assay is intended for use specially in assisting diagnosis and monitoring of pregnancy
Total Beta Human Chorionic Gonadotropin eCLIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000117_a059caeedc4b3103e6b385463559ec6b_f9ba431761d1e1885a5952cede6c024d. This device is marketed under the brand name eCLIA. The license holder is Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED), and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.